News

UTSW researchers discover how food-poisoning bacteria infect the intestines

Findings revealing efficient assembly of virulence machine could lead to development of treatments for diseases caused by gut pathogens
University of Texas Southwestern Medical Center
By University of Texas Southwestern Medical Center
June 3, 2023

Researchers at the University of Texas Southwestern Medical Center have discovered how a bacterium that infects people after they eat raw or undercooked shellfish creates syringe-like structures to inject its toxins into intestinal cells. The findings, published in Nature Communications, could lead to new ways to treat food poisoning caused by Vibrio parahaemolyticus.

Kim Orth, Ph.D., is a Howard Hughes Medical Institute Investigator, a member of the National Academy of Sciences, and a W.W. Caruth, Jr. Scholar in Biomedical Research, and holds the Earl A. Forsythe Chair in Biomedical Science.
Kim Orth is a Howard Hughes Medical Institute investigator.

“We have provided the first visual evidence of how a gut bacterial pathogen uses this assembly method to build a syringe to deliver a lethal injection to intestinal cells,” said Kim Orth, a professor of molecular biology and biochemistry and a Howard Hughes Medical Institute investigator at UTSW. “This work provides a new view of how enteric bacteria when exposed to bile acids efficiently respond and build a virulence system.”

This is a figure from the paper “Membrane-localized expression, production and assembly of Vibrio parahaemolyticus T3SS2 provides evidence for transertion.” It shows a two-step transertion model for the localized membrane assembly of the T3SS2 apparatus in V. parahaemolyticus.
This is a figure from the paper “Membrane-localized expression, production and assembly of Vibrio parahaemolyticus T3SS2 provides evidence for transertion.” It shows a two-step transertion model for the localized membrane assembly of the T3SS2 apparatus in V. parahaemolyticus.

V. parahaemolyticus, commonly found in warm coastal waters, is a leading cause of seafood-related food poisoning. People infected often have diarrhea, cramping, vomiting, fever and chills.

Researchers knew that V. parahaemolyticus injects molecules into human cells using a structure called the type III secretion system 2 (T3SS2). However, these syringes, composed of 19 different proteins, are not produced or assembled until the bacteria are inside the intestines. Scientists were not sure exactly how this occurs.

The latest findings build on the work of a previous study by the Orth lab.  Orth and her colleagues tagged components of the V. parahaemolyticus T3SS2 with fluorescent markers and used super-resolution microscopy to track their locations as the bacteria were grown in different conditions. The researchers discovered that when V. parahaemolyticus is exposed to bile acids — digestive molecules in the intestines — the bacteria move DNA containing the T3SS2 genes close to their membrane.

Then, at the exact site where the T3SS2 is needed, V. parahaemolyticus transcribes that DNA into RNA, translates the RNA into protein, and assembles the components of the T3SS2 through the membrane in a process known as transertion. “It is like watching the assembly of a factory that produces a large molecular machine within an hour,” Orth said. 

Karan Kaval, Ph.D., a UTSW research specialist and member of the Orth lab, was first author of the study.
Karan Kaval, a UTSW research specialist and member of the Orth lab, was first author of the study.

These steps were previously thought to occur in more disparate locations around a cell, but pulling the machinery together into one place on the bacterium’s membrane likely helps V. parahaemolyticus more quickly and efficiently build the T3SS2 and infect cells. Since other disease-causing gut bacteria contain molecular components similar to V. parahaemolyticus, the phenomenon of transertion may be widely used, the researchers hypothesize.

“Our findings imply that other gastrointestinal pathogens may also use this mechanism to mediate efficient assembly of complex molecular machines in response to environmental cues,” said UTSW research specialist Karan Kaval, first author of the paper.

More work is needed to know which bacteria use transertion to build their T3SS structures and whether drugs could be developed that block transertion to treat V. parahaemolyticus infections.

UTSW researcher Jananee Jaishankar also contributed to this study.

This article was first published by the University of Texas Southwestern Medical Center. Read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center

The University of Texas Southwestern Medical Center integrates pioneering biomedical research with exceptional clinical care and education. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research to new clinical treatments.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Transforming learning through innovation and collaboration
Award

Transforming learning through innovation and collaboration

Nov. 22, 2024

Neena Grover will receive the William C. Rose Award for Exemplary Contributions to Education at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.